WHG is a Health Policy Consulting & Government Relations Firm Based in Washington D.C. on Pennsylvania Ave. Between the Capitol & the White House

WHG Helps Clients Develop & Execute Successful Health Policy & Government Relations Strategies to Maximize Enterprise Value – COVID New Era & Beyond
Picture
Year two of the Covid-19 SARS pandemic, the country is transitioning out of lockdowns and virtual communication into a new era of COVID-19 behavior challenges requiring the U.S. healthcare delivery system to continue to evolve.

Some of the major challenges affecting the public and private sector health policy decision-making include but not limited to:
  • Vaccine mandates, mask mandates and the natural immunity debate as 80% of the 12 years of age and older population have received at least one vaccine shot.
  • Managing the recent delta variant surge, subsequent decline and the potential for another variant.
  • Coping with the reality that the EUA vaccines until October 29, 2021 were authorized only for 12 years of age and older, leaving about 48.4M or 14.6% of the U.S. population still at risk without the option of a vaccine for potential protection.
  • 18.3% of all the new positive COVID-19 cases reported in the last 90 days are in the age group of less than 12 years of age.

WHG Provides Summary Updates on The Latest Vaccine Administration Data and COVID-19 Tracking
Wells Health Group Areas of Expertise
Health Policy Consulting
​CPT & HCPCS Coding
Government Relations
​Advocacy & Legislation
M&A Consulting
​Reimbursement Validation

Why Choose WHG ​- Innovators in Health Policy & Government Relations

WHG's innovative approach to health policy consulting and government relations is built on a two-step sequential process founded on 70+ years successful healthcare industry and government relations experience:
  1. A core set of essential strategy analytics - deep dive into the client’s requirements and an analysis of supporting data to develop executable solutions
  2. Focused reimbursement pathways - evidence based and data driven.
Post Pandemic New Era and Beyond - Federal Agencies, Congress and the Administration require more and more decision-making to be made based upon clinical data and scientific evidence.
WHG's two-step process remains the successful foundation of our innovative approach to health policy consulting and government relations - clinical data evidence. Our proven processes helps us collaborate with clients to more effectively navigate all the new emergency use federal regulations.

​​Why Our 70+ Years Industry & Government Relations Experience Matters

  • Because ​we come from the healthcare industry - WHG is uniquely positioned to best understand our client’s challenges and develop targeted government relations strategies.
  • Because of our government relations experience representing industry, we knew it was critical for WHG to have a Washington D.C. presence.
  • Because WHG is strategically located on Pennsylvania Avenue between the Capitol and the White House and just six blocks from the main HHS building, WHG has been able to more readily access face-to-face meetings at multiple levels of the HHS Agencies and on Capitol Hill.
  • Because of WHG's previous years of Washington D.C. presence, participating in face-to-face meetings at multiple levels of  the HHS Agencies and on Capitol Hill, we know how to leverage  virtual access  to multiple levels of the HHS Agencies and on Capitol Hill.​​
  • Because of WHG’s years of healthcare and government relations experience we understand how to acclimatize and manage the challenge of evolving political ideology and the potential impact on the healthcare delivery system.
Federal Regulations - CMS reimbursement processes, CDC guidance, FDA regulations and NIH expanded research
are not intuitive and can lead to uncertainties and market access complications especially during the HHS Emergency Use Authorization (EUA) Authority